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The intestine is inhabited by a large microbial community consisting primarily of anaerobes and, to a lesser
extent, facultative anaerobes, such as Escherichia coli, which we have shown requires aerobic respiration to
compete successfully in the mouse intestine (S. A. Jones et al., Infect. Immun. 75:4891-4899, 2007). If facul-
tative anaerobes efficiently lower oxygen availability in the intestine, then their sustained growth must also
depend on anaerobic metabolism. In support of this idea, mutants lacking nitrate reductase or fumarate
reductase have extreme colonization defects. Here, we further explore the role of anaerobic respiration in
colonization using the streptomycin-treated mouse model. We found that respiratory electron flow is primarily
via the naphthoquinones, which pass electrons to cytochrome bd oxidase and the anaerobic terminal reduc-
tases. We found that E. coli uses nitrate and fumarate in the intestine, but not nitrite, dimethyl sulfoxide, or
trimethylamine N-oxide. Competitive colonizations revealed that cytochrome bd oxidase is more advantageous
than nitrate reductase or fumarate reductase. Strains lacking nitrate reductase outcompeted fumarate reduc-
tase mutants once the nitrate concentration in cecal mucus reached submillimolar levels, indicating that
fumarate is the more important anaerobic electron acceptor in the intestine because nitrate is limiting. Since
nitrate is highest in the absence of E. coli, we conclude that E. coli is the only bacterium in the streptomycin-
treated mouse large intestine that respires nitrate. Lastly, we demonstrated that a mutant lacking the NarXL
regulator (activator of the NarG system), but not a mutant lacking the NarP-NarQ regulator, has a coloni-
zation defect, consistent with the advantage provided by NarG. The emerging picture is one in which gene
regulation is tuned to balance expression of the terminal reductases that E. coli uses to maximize its compet-
itiveness and achieve the highest possible population in the intestine.
The mouse colon is home to at least several hundred bac-
terial species and more than 100 billion bacteria per g of
contents, a microbial community dominated by anaerobes with
essentially no aerobes (2, 38, 57, 68). It is becoming increas-
ingly clear that facultative anaerobes consume oxygen and
thereby modify their host environment. For example, kidney
infection caused by uropathogenic Escherichia coli results in
local ischemia (47). The facultatively anaerobic enteric patho-
gen Shigella flexneri responds to oxygen in the gut by modulat-
ing virulence gene expression (45). It has been postulated that
the importance of Salmonella motility for chemotaxis through
the mucus layer (61) may be due to aerotaxis (44). That E. coli
requires cytochrome bd oxidase to gain a competitive advan-
tage implies that the colon is not the anaerobic environment
that many consider it to be (30). Here, we explore the possi-
bility that efficient oxygen scavenging by E. coli in the intestine
causes it to depend also on anaerobic respiration.
To maximize their energy efficiency, enteric bacteria such as
E. coli possess elaborate genetic regulatory networks for sens-
ing oxygen (32), the redox state of the electron transport sys-
tem (19, 43, 58), and the availability of alternative anaerobic
electron acceptors (70). We previously showed that the anaer-
obic transcription factor Fnr, as well as the aerobic respiratory
controller ArcA, is required for commensal and pathogenic E.
coli strains to colonize the intestine in competition with wild-
type E. coli parent strains (30). We further showed that mu-
tants lacking ATPase (completely respiration deficient) and
mutants lacking terminal reductases for low oxygen, nitrate, or
fumarate each are at an extreme disadvantage in competition
with their wild-type parents for colonization of the streptomy-
cin-treated mouse intestine (30). On the basis of these results,
we hypothesize that E. coli maximizes its cell yield from limited
carbon sources by using the most energy-efficient respiratory
electron acceptors that are available to it in the intestine.
There is clear evidence to indicate that oxygen is present in
the gut (24, 37). We hypothesize that oxygen-scavenging fac-
ultative anaerobes such as E. coli create an anaerobic environ-
ment for the numerically dominant intestinal anaerobes, in
analogy to the situation in anaerobic digesters (28). Our re-
search supports this idea. Nevertheless, our experiments also
indicate that reduction of the anaerobic electron acceptors
nitrate and fumarate is essential for E. coli to maintain its
competitive advantage in the intestine (30). We take this as
evidence that the ability to efficiently respire oxygen and main-
tain an anaerobic environment (into which oxygen continu-
ously diffuses) likewise requires maximum efficiency under an-
aerobic conditions. Here, we explore the possibility that
additional alternative electron acceptors, i.e., nitrite, dimethyl
sulfoxide (DMSO), and trimethylamine N-oxide (TMAO),
support E. coli intestinal colonization. The results indicate that
nitrate and fumarate are the only anaerobic electron acceptors
used by commensal and pathogenic strains of E. coli to colo-
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nize the intestine. In addition, we present further evidence that
anaerobic electron transport chain components, as well as the
NarX-NarL two-component system that governs gene expres-
sion for anaerobic respiratory systems, are necessary for com-
petitive fitness in the streptomycin-treated mouse intestine.
MATERIALS AND METHODS
Bacterial strains and growth conditions. In Table 1 we list the E. coli mutants
used in this study; these were derived from E. coli MG1655 Strr (streptomycin
resistant), a K-12 strain isolated from a human (4), and E. coli EDL933 Strr, the
prototypical O157:H7 strain (53). For colonization experiments, the wild-type
strains were E. coli MG1655 Strr Nalr (nalidixic acid resistant) (52) and E. coli
EDL933 Strr Nalr (51); Nalr is used to distinguish the wild type from null allele
mutants. Null alleles were constructed by using the allelic replacement method of
Datsenko and Wanner (14) as described previously (8), such that target genes
were deleted and replaced with kanamycin or chloramphenicol resistance cas-
settes (used as selectable markers in mouse colonization assays described below).
The null allele strains are identified in the text by the genes that were deleted;
single gene deletions began with the start codon and ended with the stop codon,
and multiple gene deletions began with the start codon of the first gene deleted
and ended with the stop codon of the last gene deleted. Strains containing
multiple mutations were constructed by sequential allelic replacement; removal
of the first inserted cassette with FLP recombinase (14) was followed by subse-
quent allelic replacement(s) and removal of the insertion as necessary, leaving
the selectable marker in the last mutation made. It is possible that mutations
were inadvertently introduced elsewhere on the genome during strain construc-
tion. However, we would argue that this was not the case because the allelic
replacements described herein were obtained with a frequency that varied less
than 1 order of magnitude. In addition, the results obtained in two different
genetic backgrounds (EDL933 and MG1655) were essentially identical. The
narXL and narP mutations were moved from strains VJS2458 and VJS4322,
respectively, into the E. coli MG1655 Strr background by allelic replacement.
Mutations were verified by phenotype and DNA sequence analyses.
Phenotype analysis. MOPS [3-(N-morpholino)propanesulfonic acid] defined
medium was used for phenotype analysis, as described previously (8). Anaerobic
cultures were grown in sealed Balch culture tubes filled to the top with N2-
sparged medium. To test for nitrate or fumarate respiration, mutant strains were
grown anaerobically overnight in MOPS medium with glycerol (1.6%) as the
carbon source and either 50 mM nitrate or 50 mM fumarate as the electron
acceptor. Cell growth was monitored spectrophotometrically at 600 nm (as the
optical density at 600 nm [OD600]).
High-performance liquid chromatography (HPLC) analysis. For anion anal-
ysis of mucus, we used a Dionex DX-500-Microbore system with a 10-l injection
volume, an IonPac AS11 column (at 30°C) with a 1 to 25 mM NaOH gradient as
the eluent at a 0.5-ml/min flow rate, and a suppressed conductivity detector with
the ASRS-ULTRA 2-mm AutoSuppression mode. The regression coefficient for
the standard curve was used to demonstrate the linearity of the peak area with
respect to concentration. The limit of detection of nitrate in this system was 3
M. Mouse cecal mucus was isolated from the ceca of CD-1 male mice and
lyophilized as described previously (72). Mucus samples from 5 mice were pooled
and assayed in triplicate.
Mouse colonization experiments. Streptomycin-treated mice have been used
since 1954 to overcome the colonization resistance that prevents colonization of
conventional animals by experimentally introduced enteric bacteria (7). We have
made extensive use of the streptomycin-treated mouse model to study nutritional
factors that govern colonization of the mouse large intestine by E. coli and
Salmonella enterica serovar Typhimurium (3, 8, 16, 18, 30, 31, 34, 35, 48, 49, 51,
52). Treatment of mice with streptomycin selectively removes facultatively an-
aerobic E. coli bacteria, enterococci, streptococci, lactobacilli, and anaerobic
lactobacilli and bifidobacteria without changing the overall populations of an-
aerobes, including Bacteroides and Eubacterium (25). Therefore, the streptomy-
cin-treated mouse model allows colonization by experimentally introduced E.
coli strains and competition with large numbers of strict anaerobes and, thus, is
our model of choice for studying competition among E. coli strains in the
intestine. Stable colonization requires that streptomycin treatment be continued
for the duration of the experiments. For E. coli EDL933, we emphasize that
streptomycin-treated mice are used to model colonization, not pathogenesis (13).
Briefly, CD-1 male mice, 6 weeks of age, are given drinking water containing
streptomycin sulfate (5 g/liter) for 24 h, which by removing the native facultative
anaerobes opens the niche for E. coli to colonize (50). Following 18 h of star-
vation for food and water, the mice are fed 1 ml of 20% (wt/vol) sucrose
containing 105 CFU of E. coli strains grown overnight in Luria broth. After the
bacterial suspension is ingested, both food (Teklad mouse and rat diet; Harlan,
Madison, WI) and streptomycin-water are returned to the mice, and 1-g samples
of feces are collected after 5 and 24 h and on odd-numbered days thereafter.
Mice are housed individually in cages without bedding and are placed in clean
cages at 24-h intervals. Fecal samples (1 g) are therefore no older than 24 h. Each
fecal sample is homogenized in 10 ml of 1% Bacto tryptone (Difco), diluted in
the same medium, and plated onto MacConkey agar plates containing either
streptomycin (100 g/ml) and nalidixic acid (50 g/ml) to count wild type CFU
or streptomycin and kanamycin (40 g/ml) or chloramphenicol (30 g/ml) to
count CFU of the null allele mutants. Streptomycin sulfate, chloramphenicol,
and nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). The limit
of detection for fecal plate counts is 102 CFU/g feces. Each colonization exper-
iment was replicated at least twice, with essentially identical results. Pooled data
from at least 2 independent experiments (a total of 6 mice) are presented in the
figures as the log of fecal plate counts.
RESULTS
Anaerobic quinones contribute to respiration in the intes-
tine. Previously, we showed that E. coli mutants lacking cyto-
chrome bd oxidase, nitrate reductase (Nar), or fumarate re-
ductase (Frd) are eliminated from the intestine by competition
TABLE 1. Strains used in this study
Strain Relevant genotype,phenotype, or descriptiona
Source or
reference
EDL933 Wild-type O157:H7 Alison O’Brien
EDL933 Strr Spontaneous Strr 51
EDL933 Strr Nalr Spontaneous Nalr 51
MG1655 Wild type (CGSC 7740) CGSCb
MG1655 Strr Spontaneous Strr 52
MG1655 Strr Nalr Spontaneous Nalr 52
VJS4322 (narP)253::Tn10d(cat) Valley Stewart
VJS2458 (narXL)240::Knr Valley Stewart
Derivatives of EDL933 Strr
cydAB mutant (cydAB)::cat This study
cydDC mutant (cydDC)::cat This study
dmsAB mutant (dmsAB)::cat This study
frdA mutant frdA::Knr This study
napDA mutant (napDA)::cat This study
narG mutant narG::Knr This study
narZ mutant narZ::cat This study
narG narZ mutant narG narZ::cat This study
narG narZ napDA mutant narG narZ (napDA)::cat This study
ubiCA mutant (ubiCA)::cat This study
ubiE mutant ubiE::cat This study
Derivatives of MG1655 Strr
cydAB mutant (cydAB)::cat This study
cydDC mutant (cydDC)::cat This study
dmsAB mutant (dmsAB)::cat This study
dmsAB ynfEFGH mutant (dmsAB) (ynfEH)::cat This study
frdA mutant frdA::Knr This study
napDA mutant (napDA)::cat This study
narG mutant narG::Knr This study
narZ mutant narZ::cat This study
narG narZ mutant narG narZ::cat This study
narG narZ napDA mutant narG narZ (napDA)::cat This study
narP mutant (narP)253::Tn10d(cat) This study
narXL mutant (narXL)240::Knr This study
nirBD mutant (nirB-nirD)::cat This study
nrfA mutant nirfA::cat This study
nrfA nirBD mutant nirfA (nirBD)::cat This study
torCA mutant (torCA)::cat This study
torYZ mutant (torYZ)::cat This study
torCA torYZ mutant (torCA) (torYZ)::cat This study
torCA torYZ dmsAB mutant (torCA) (torYZ)
(dmsAB)::cat
This study
ubiCA mutant (ubiCA)::cat This study
ubiE mutant ubiE::cat This study
a Nalr, nalidixic acid resistance; Strr, streptomycin resistance; Knr, kanamycin
resistance.
b E. coli Genetic Stock Culture Collection, Yale University.
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with the wild-type parent strains (30). The relative contribu-
tions of aerobic and anaerobic respiratory processes to colo-
nization are not known. The respiratory dehydrogenases are
linked to the terminal reductases by a pool of quinones com-
prising ubiqinone (UQ), menaquinone (MQ), and demethyl-
menaquinone (DMQ). Theoretically, this allows formation of
branched respiratory chains in which most dehydrogenases can
interact with most terminal reductases (70). However, the mid-
point potential of UQ is best suited for aerobic respiration,
whereas MQ and DMQ are involved primarily in anaerobic
respiration, with DMQ having a midpoint potential between
those of UQ and MQ (70). In general, anaerobic terminal
reductases have higher activity with MQ and DMQ, cyto-
chrome bo3 has the highest activity with UQ, and cytochrome
bd apparently uses both UQ and MQ (23). Electron flow to
fumarate, TMAO, and nitrite is via both MQ and DMQ, while
electron flow to DMSO is primarily via MQ. The primary Nar
enzyme (NarG) uses UQ and MQ but not DMQ (77). While all
three quinones are present under both aerobic and anaerobic
conditions, their relative concentrations vary with oxygen ten-
sion, with DMQ increasing rapidly and MQ increasing more
slowly when oxygen is limited (6, 69, 75). Accordingly, while
DMQ would be in the greatest abundance under the low oxy-
gen tension in the mouse intestine (30), DMQ alone would not
be sufficient for colonization since electron flow to nitrate and
low oxygen would require MQ under these conditions. Thus,
we predicted that respiratory electron flow via both MQ and
DMQ supports colonization of the intestine by E. coli.
To confirm this hypothesis, we used mutants lacking one or
more quinone biosynthetic pathways (46). Specifically, as
shown in Table 2, ubiCA mutants cannot make UQ (33, 78, 80),
ubiE mutants cannot make UQ or MQ (36, 77), and menA
mutants cannot make MQ or DMQ (65, 79). The ubiCA, ubiE,
and menA mutations were constructed in E. coli MG1655 and
E. coli EDL933, the mutants were fed to streptomycin-treated
mice together with the respective wild-type parent strains at
105 CFU of each strain, and the population of each strain was
monitored by using fecal plate counts. The results of these
experiments are shown in Table 2. The ubiCA mutants, lacking
UQ, cocolonized with the wild type, which is evidence that MQ
and DMQ are sufficient for colonization of the intestine by E.
coli. The menA mutants, lacking both MQ and DMQ, were
able to increase in population during the initiation stage of
colonization (24 h), although not to the same extent as the wild
type, but were completely eliminated (reaching levels of 102
CFU/g feces) by day 9 of the experiment. One interpretation of
these results is that UQ helps support colonization initiation
when MQ is unavailable. Given that the passage of electrons to
oxygen is primarily via UQ when oxygen is not limiting, it may
be that UQ is used during the initiation stage because oxygen
levels are relatively high in animals that have been treated with
streptomycin to remove the facultative anaerobes prior to col-
onization with E. coli. The ubiE mutants, which have only
DMQ, failed to initiate colonization in competition with the
wild type (in the first 24 h) and were eliminated from the mice
(reaching levels of 102 CFU/g feces), which indicates that
anaerobic electron flow via MQ in the intestine is more ad-
vantageous than that via DMQ and further supports the idea
that UQ is used during colonization initiation. All four of the
strains with competitive colonization defects (E. coli MG1655
ubiE, E. coli MG1655 menA, E. coli EDL933 ubiE, and E. coli
EDL933 menA) colonized to yield between 107 and 108 CFU/g
feces when fed alone to mice, indicating that the colonization
defects were due to an inability to compete with the wild type
rather than a general inability to grow in the intestine (data not
shown). In summary, we conclude that respiratory electron
flow via MQ and DMQ to cytochrome bd oxidase and anaer-
obic terminal reductases supports colonization of the intestine
by E. coli.
Alternative electron acceptors DMSO, TMAO, and nitrite
do not support colonization. In addition to its ability to respire
nitrate and fumarate, E. coli possesses systems for reduction of
DMSO, TMAO, and nitrite as terminal electron acceptors
(11). To investigate these alternative respiratory pathways in
the intestine, each of the redundant terminal reductase gene
systems was knocked out in E. coli MG1655 by allelic replace-
TABLE 2. Competitive colonization by E. coli quinone biosynthesis mutants and alternative anaerobic electron acceptor mutantsa
Mutant genotype
Presence or absenceb of: Difference between E. coli EDL933wild-type and mutant strains on:
Difference between E. coli MG1655
wild-type and mutant strains on:
UQ MQ DMQ Day 1 Day 9 Day 1 Day 9
(ubiCA)    0.21  0.05 0.71  0.14 0.78  0.27 0.24 0.22
ubiE    3.26  0.13 5.80  0.13 4.04  0.09 5.03 0.20
menA    1.23  0.16 5.15  0.19 1.00  0.24 5.66  0.11
dmsABC    0.21  0.11 0.31  0.25 0.21 0.18 0.21  0.17
ynfEFGH    NDc ND 0.16 0.48 0.71 0.25
dmsABC ynfEFGH    ND ND 0.11  0.17 0.62 0.12
torCA    0.52  0.13 0.10  0.11 0.18  0.16 0.15  0.26
torYZ    ND ND 0.47  0.37 0.51 0.17
torCA torYZ    ND ND 0.61  0.54 0.15 0.58
dmsABC torCA torYZ    ND ND 0.38  0.19 0.26 0.23
nirBD    0.30  0.24 0.49  0.46 0.05  0.16 0.64 0.30
nrfA    ND ND 0.02  0.25 0.11 0.21
nirBD nrfA    ND ND 0.21  0.25 0.21 0.11
a Mice were fed 105 CFU each of the mutant and its wild-type parent. The average differences between the wild-type strain and its isogenic mutant (among 6 mice)
are represented as the log number of wild-type CFU per gram of feces minus the log number of mutant CFU per gram of feces  the standard error of the mean on
days 1 and 9 of the experiments. All values shown in bold are statistically significant: P  0.001 (Student’s t test).
b Presence () or absence () of UQ, MQ, or DMQ, in accordance with the indicated genotypes.
c ND, not determined.
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ment, the mutant strains were fed to mice together with their
wild-type parents at 105 CFU of each strain, and the relative
populations of the strains in fecal plate counts were deter-
mined. The DmsABC system reduces both DMSO and
TMAO; a paralogous YnfEFGHI system for DMSO reduction
(41) is now thought to reduce selenium (22). Mutants contain-
ing deletions of either or both of the corresponding gene sys-
tems were found to cocolonize with wild-type E. coli MG1655,
indicating that reduction of DMSO does not provide a coloni-
zation advantage in the intestine (Table 2). The TorCAD and
TorYZ systems, in addition to DmsABC, are responsible for
TMAO reduction (9). Mutants lacking these TMAO reductase
systems, either individually or collectively, cocolonized with the
wild-type parent strain, indicating that reduction of TMAO
does not contribute to the fitness of E. coli MG1655 in the
intestine (Table 2). Lastly, to investigate the contribution of
nitrite reductase to colonization fitness, we constructed mu-
tants lacking either or both the cytoplasmic NirBCD and
periplasmic NrfABCD nitrite reductase systems. We found
that in competition experiments, each of these mutants cocolo-
nized with wild-type E. coli MG1655 (Table 2), indicating that
nitrite is not used in the intestine. Given that nitrate is used
and that the product (nitrite) is potentially toxic (40), it is
interesting that the loss of nitrite reductase does not result in
a competitive disadvantage in the intestine. From these results
we conclude that colonization of the intestine by E. coli is not
supported by respiration of DMSO, TMAO, or nitrite, either
because these electron acceptors are unavailable or because
the terminal reductases are not functionally expressed. To-
gether with results from the previous study (30), these new
results lead us to conclude that respiration of nitrate and res-
piration of fumarate, in addition to fermentation, are the only
anaerobic processes that contribute to the colonization fitness
of E. coli in the mouse intestine.
Aerobic cytochrome bd is more advantageous than anaero-
bic respiration. We sought to evaluate the relative contribu-
tions of aerobic and anaerobic respiration to colonization of
the intestine. Previously, we showed that the low-affinity, high-
oxygen-tension cytochrome bo3 oxidase does not contribute to
colonization but that the high-affinity, low-oxygen cytochrome
bd oxidase is essential for competition with wild-type E. coli in
the intestine (30). The E. coli EDL933 and E. coli MG1655
cydAB mutants were competed against E. coli EDL933 and E.
coli MG1655 narG mutants, respectively, by feeding the two
strains together to mice at 105 CFU of each strain. In both
experiments the cydAB mutants were eliminated from the in-
testine (Fig. 1). Likewise, the E. coli EDL933 and E. coli
MG1655 cydDC mutants were eliminated from the intestine
during competition against E. coli EDL933 and E. coli
MG1655 frdA mutants, respectively (Fig. 1). We showed pre-
viously that E. coli cydDC mutants that cannot assemble cyto-
chrome bd oxidase in the membrane (54) have colonization
defects similar to those of cydAB mutants (30). These results
indicate that aerobic respiration via cytochrome bd oxidase
provides an advantage over anaerobic respiration of nitrate or
fumarate in the intestine.
The primary Nar enzyme contributes a major colonization
advantage. There are three nitrate reductase systems in E. coli
(70). Previously, we showed that strains lacking the primary
enzyme, NarG, have a significant colonization defect in com-
petition with the wild type but that strains lacking the second-
ary cytoplasmic enzyme NarZ or Nap are as competitive as the
FIG. 1. Competition between mutants lacking cytochrome bd and mutants lacking either nitrate reductase or fumarate reductase. Upper left,
E. coli EDL933 cydAB (EDL cydAB) versus E. coli EDL933 narG (EDL narG); upper right, E. coli EDL933 cydDC (EDL cydDC) versus E.
coli EDL933 frdA (EDL frdA); lower left, E. coli MG1655 cydAB (MG cydAB) versus E. coli MG1655 narG (MG narG); lower right, E. coli
MG1655 cydDC (MG cydDC) versus E. coli MG1655 frdA (MG frdA).
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wild type, which suggests that NarG is the major contributor to
nitrate respiration in the intestine (30). Strains lacking all three
systems had colonization defects up to 1 log more severe than
the strain lacking NarG alone, which suggests that the other
systems may contribute modestly to colonization in the ab-
sence of NarG (30). To further evaluate the relative impor-
tance of the Nar systems, we competed narG mutants individ-
ually against narZ and napDA mutants (Fig. 2). In competition
with the narZ mutant, the narG mutants had a 4-log coloniza-
tion defect. In competition with the napDA mutant, the narG
mutant initially reached the same high population (108 CFU/g
feces) before showing a 2-log defect at day 7 and then a more
rapid decline to an undetectable number (102 CFU/g feces) by
day 13 of the experiment. These results confirm that electron
flow to nitrate occurs primarily via NarG.
Nitrate availability dictates competition for anaerobic elec-
tron acceptors in the intestine. To determine which of the two
anaerobic electron acceptors used by E. coli in the intestine
provides the superior colonization advantage, we competed E.
coli EDL933 narG narZ with E. coli EDL933 frdA and E. coli
MG1655 narG narZ with E. coli MG1655 frdA (Fig. 3). In both
experiments the frdA mutants, which can respire nitrate but
not fumarate, initially (at day 3 or day 5) had a colonization
advantage but subsequently declined in numbers relative to the
narG narZ mutants, which persisted at relatively high popula-
tions. Apparently, nitrate respiration provides an advantage
during the initial stage of colonization, when the level of ni-
trate is expected to be high if no other members of the micro-
bial community consume it. However, we conclude that the
ability to respire fumarate provides a more significant coloni-
zation advantage than the ability to respire nitrate for long-
term persistence of established populations of E. coli.
To determine the role of nitrate availability in the competi-
tion between Nar and Frd mutants, we measured the nitrate
concentration in cecal mucus after association with 105 CFU
each of E. coli EDL933 narG narZ napDA and E. coli EDL933
frdA (Table 3). In control experiments, mice colonized with E.
coli EDL933 Strr (the wild type) had undetectable levels of
nitrate (3 M) in their cecal mucus on days 1, 5, and 11
following association. Mice colonized with E. coli EDL933
FIG. 2. Competition between nitrate reductase mutants. Top, E.
coli MG1655 napDA versus E. coli MG1655 narG; middle, E. coli
MG1655 narZ versus E. coli MG1655 narG; bottom, E. coli
EDL933 narZ versus E. coli EDL933 narG.
FIG. 3. Competition between nitrate reductase and fumarate re-
ductase mutants. Top, E. coli EDL933 narG narZ versus E. coli
EDL933 frdA; bottom, E. coli MG1655 narG narZ versus E. coli
MG1655 frdA.
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narG narZ napDA alone had an average of 2.8 mM nitrate.
Following association with E. coli EDL933 narG narZ napDA
and E. coli EDL933 frdA, nitrate in cecal mucus declined to a
mean  standard error of the mean of 0.77  0.31 mM on day
1, reached 0.31 0.25 mM on day 5, and was undetectable (3
M) on day 11 of the experiment (Table 3). In the colonization
experiment (Fig. 3), the Nar Frd strain increased in popu-
lation at 24 h, consistent with the availability of nitrate,
whereas the Nar Frd strain was unable to increase in pop-
ulation and remained at 6 log CFU/g feces. By day 3 of the
experiment, as the nitrate concentration decreased (presum-
ably through respiratory metabolism by the competing Nar
strain), the Nar Frd strain declined in population whereas
the Nar Frd strain persisted. Thus, the population of the
Nar Frd strain declined as nitrate diminished, indicating
that respiration of nitrate by E. coli in the intestine is limited by
nitrate availability but that fumarate is more readily available
and therefore more important for persistence in the intestine.
The NarX-NarL regulatory circuit contributes to coloniza-
tion. Regulation of anaerobic respiration is thought to contrib-
ute to the success of E. coli in changing environments (10).
Thus, it was of interest to determine the relative contributions
to colonization of the two two-component systems that control
anaerobic gene systems involved in nitrate respiration. NarG is
activated by the NarX-NarL two-component system when ni-
trate is abundant, and NarX-NarL represses Nap, which is
activated by the NarQ-NarP system when nitrate is 3 orders of
magnitude lower (74, 76). To determine the relative contribu-
tions of the NarX-NarL and NarQ-NarP systems to coloniza-
tion, mice were fed E. coli MG1655 narXL or E. coli MG1655
narP together with the wild-type parent at 105 CFU of each
strain and the relative populations of the strains were deter-
mined (data not shown). The narXL mutant had a 1-log colo-
nization defect (P  0.05) in competition with the wild type,
and the narP mutant cocolonized with the wild type. As dis-
cussed further below, it makes sense that the structural gene
(narG) colonization defect is more severe than the regulatory
gene (narXL) defect. These results confirm the importance of
NarG for colonization, since the main function of NarX-NarL
is to activate NarG.
Aerobic respiratory control is more important than aerobic
respiration. Previously, we showed that Fnr and ArcA mutants
are eliminated from the intestine in competition with the wild
type (30). Since mutants lacking the high-affinity cytochrome bd
oxidase have a colonization defect, we concluded that E. coli
experiences microaerobic or alternately aerobic and anaerobic
conditions in the intestine (30). Interestingly, the two-component
ArcAB system is most active at low oxygen tension (1), i.e., at
oxygen levels present in the large intestine (24). Thus, we consid-
ered the possibility that ArcAB contributes to colonization fitness
because it activates transcription of the cytochrome bd oxidase
genes (24). To test whether the loss of ArcAB activation of cyto-
chrome bd was the sole reason for the previously observed colo-
nization defect of the arcA mutant in competition with the wild
type (30), arcA::kan and (cydAB)::cat mutants of E. coli
EDL933 and MG1655 were fed together to mice at a level of 105
CFU of each strain/mouse. The arcA mutants with either genetic
background were quickly eliminated during competition with the
cydAB mutants (Fig. 4). These results indicate that failure to
activate cydAB under microaerobic conditions is not the sole
reason for the colonization defect of the arcA mutant and imply
that other aspects of ArcAB control, such as repression of cyto-
chrome bo3 oxidase genes and other genes that participate in
aerobic processes (e.g., the tricarboxylic acid [TCA] cycle), are
also important in the intestine.
DISCUSSION
Commensal E. coli MG1655 and pathogenic E. coli EDL933
must respire oxygen, nitrate, and fumarate to be competitive in
FIG. 4. Competition between E. coli EDL933 arcA and E. coli
EDL933 cydAB (top) and E. coli MG1655 arcA and E. coli MG1655
cydAB (bottom).
TABLE 3. HPLC analysis of nitrate in mouse cecal mucus
Strain NO3
 concna (mM)
in mucus
Day of
colonization
EDL933 Strr ND 1
ND 5
ND 11
narG narZ napDA mutant 2.76  0.27 1
2.89  0.33 5
2.65  0.49 11
narG narZ napDA frdA mutant 0.77  0.31 1
0.31  0.25 5
ND 11
a Nitrate was measured in samples of cecal mucus prepared from mice colo-
nized with the indicated E. coli strains. Values are means  standard errors of
the means for samples from 5 mice. ND, not detected (3 M).
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the intestine (30). Analysis of a series of quinone biosynthesis
mutants (Table 2) demonstrated that electron flow in colo-
nized E. coli is primarily via the naphthoquinone pool (MQ
and DMQ), which is used by cytochrome bd oxidase and the
anaerobic terminal reductases that use nitrate and fumarate.
Competition experiments revealed that respiration of oxygen
provides a greater colonization advantage than anaerobic res-
piration (Fig. 1). NarG is the most important of the three
systems for nitrate respiration (Fig. 2). Similarly, a mutant
lacking the NarX-NarL regulatory system, which activates
NarG synthesis, had a colonization defect. Competition of
mutants lacking nitrate reductase with mutants lacking Frd
revealed an interesting interplay between the two strains,
which can be explained by nitrate limitation in the cecum
(Fig. 3 and Table 3). Lastly, competition between a mutant
lacking the aerobic respiratory control system and a mutant
lacking cytochrome bd oxidase indicated that the role of
ArcA in colonization extends beyond simple activation of
cydAB (Fig. 4).
The emerging picture is one in which E. coli generates the
energy it requires to colonize the mammalian intestine by
respiring oxygen, nitrate, and fumarate. As would be expected
when considering the potential of these processes to generate
energy (11), oxygen is favored over nitrate or fumarate. How-
ever, it is clear from published studies (24, 37) that oxygen is
limiting in the intestine, consistent with our observations that
anaerobic respiration also contributes to colonization. The
studies described herein support the conclusion that nitrate,
too, is limiting in the intestine. In this regard, E. coli can be
thought of as a scavenger of available electron acceptors, using
whichever one is available to maximize its competitiveness and
achieve the highest possible population.
Availability and use of electron acceptors. Oxygen diffuses
from the intestinal epithelium into the mucus layer (59). Fu-
marate is generated endogenously from carbohydrates via gly-
colysis and the reductive branch of the TCA cycle and also
from available C4-dicarboxylates and related compounds such
as aspartate via metabolism (29). In humans, dietary nitrate,
mostly from vegetables (42), as well as nitrate biosynthesis
(21), contributes to the available nitrate in the body. While it
is known that the availability of nitrate in the ferret intestine
increases with antibiotic treatment to remove the microbiota
(15), microbial nitrate metabolism in animals and humans re-
mains largely unexplored.
We measured 2.8 mM nitrate in cecal mucus prepared from
mice that were treated with streptomycin to remove native E.
coli and subsequently colonized with an E. coli EDL933 mutant
that is completely Nar deficient. Upon colonization of the
streptomycin-treated mouse intestine with wild-type E. coli
EDL933, the nitrate concentration was undetectable 24 h
postassociation. This suggests, first, that E. coli is the only
microorganism that consumes nitrate in the intestines of strep-
tomycin-treated mice and, second, that at least in streptomy-
cin-treated mice fed a controlled diet, intestinal nitrate is con-
sumed as fast as it becomes available. Together with our
previous results, our present results point to the intestinal
environment as one containing limiting oxygen and limiting
nitrate as the only available exogenous electron acceptors.
Terminal reductase synthesis is subject to hierarchical reg-
ulation such that electron acceptors with higher midpoint po-
tentials are used preferentially (11, 26, 39, 60, 63, 70). The
streptomycin-treated mouse model afforded the opportunity to
test the hypothesis that this paradigm also operates in vivo. Our
competition assays with streptomycin-treated mice revealed
that mutants lacking cytochrome bd oxidase are outcompeted
by mutants lacking either Nar or Frd, which is in keeping with
the observed preference for oxygen over nitrate and for nitrate
over fumarate. Given that nitrate has the potential to yield
more energy than fumarate respiration, we expected a mutant
lacking Nar to be outcompeted by a mutant lacking Frd. In-
stead, we found that Nar Frd strains had an initial advan-
tage but that after several days Nar Frd strains gained an
advantage. The population of Nar Frd strains correlated
with the availability of nitrate, i.e., the nitrate concentration in
cecal mucus was reduced to submillimolar concentrations at
the time when the Nar Frd strains became dominant, pre-
sumably because they can use fumarate. Just as in a nitrate-
limited chemostat (74), it appears that in the intestine the
respiratory activity of E. coli decreases the low initial nitrate
concentration to an undetectable level. Thus, in the strepto-
mycin-treated mouse intestine it appears that nitrate is limiting
and that fumarate, because it is generated from exogenous
carbon sources, is more abundant. The observed competition
between the Nar Frd and Nar Frd strains is what one
would predict for an ecological succession based on competi-
tion for a single nutrient that becomes limiting (66).
Role of nitrate respiration and its regulation. Evidence sug-
gests that NarG and NapA nitrate reductases function opti-
mally at relatively high and low nitrate concentrations, respec-
tively (55, 56). This predicts that the NapA enzyme would be
more important than the NarG enzyme for intestinal coloni-
zation (11). However, our results support the opposite conclu-
sion. As noted above, these results may reflect nitrate dynamics
that are particular to the streptomycin-treated mouse intestine
and colonization protocols employed in our studies. Certainly,
the relative roles for these two forms of nitrate reductase in
different natural environments deserve further study.
Dual nitrate-responsive two-component systems, NarX-
NarL and NarQ-NarP, control terminal reductase synthesis.
The NarX-NarL system activates synthesis of the NarG en-
zyme and represses synthesis of other terminal reductases,
including NapA and FrdA (62). The NarQ-NarP system plays
a more restricted role and is involved primarily in activating
NapA and NrfA synthesis (12, 62). We found a colonization
defect for the (narXL) but not the narP strain, congruent
with the colonization defect of the narG but not the
(napDA) strain.
However, whereas the narG strain exhibited an approxi-
mately 5-log defect, the (narXL) strain colonization defect
was near the detection limit, approximately 1 log. Similarly,
work with Pseudomonas aeruginosa demonstrated that a
(narGH) mutant is avirulent in Caenorhabditis elegans infec-
tion but that a (narXL) mutant exhibits nearly wild-type vir-
ulence (71). We offer two hypotheses for why the narG and
(narXL) mutant phenotypes differed in the streptomycin-
treated mouse model. First, the narG strain is devoid of the
corresponding activity whereas the narG operon is expressed at
low but detectable levels in the (narXL) strain (64). Perhaps
this low-level expression is sufficient to allow significant ni-
trate-dependent growth in this environment. Second, during
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growth with nitrate, the NarX-NarL system represses synthesis
of enzymes for the manufacture and respiration of fumarate
(12, 20, 27). Thus, the narG mutant is defective not only for
nitrate respiration but also for fumarate respiration, because of
NarX-NarL-mediated repression. In contrast, the (narXL)
mutant is able to manufacture and respire fumarate even in the
presence of nitrate. These hypotheses are not mutually exclu-
sive, and further analysis will determine if either or both are
likely to be correct.
In conclusion, our studies support the idea that E. coli in the
intestine is poised for respiration of oxygen, nitrate, and fuma-
rate as the availability of these electron acceptors dictates.
Regulation of these respiration systems under low oxygen ten-
sion would allow simultaneous production of cytochrome bd
oxidase and nitrate reductase (1, 5, 67). The low concentration
of available nitrate (and oxygen) would also allow production
of Frd (74, 76). Lastly, the flexibility of the quinone pool
facilitates electron transfer from NADH dehydrogenase to
whichever terminal reductase has a substrate available. It ap-
pears that the regulatory interplay of the ArcA, Fnr, and
NarX-NarL (and perhaps other) systems is tuned to balance
expression of the three terminal reductases that E. coli uses to
colonize the intestine.
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